NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Major… anything less than $4 by days end is just plain ridiculous.

I guess being on OTC with a cabal of price containers has its impact, but a company about to release a positive study that will be the instant new SOC when approved later this month. $4 is what the minimum should be before the first of those two gets revealed.

Why are people still worried? This has been the biggest foreshadow of an outcome in the history of the industry.

They twice published the blinded data, they then compared it to contemporaneous control data base, they got the approved new study design in EMA/UK they got their EU plus manufacturing facility approved, they are on the verge of get automated massive expansion approved, LL told us FDA accepted the SAP, and LL showed us that in the next round of research for ndGMB and rGBM, everybody gets DCVax, some get combo with the first Poly ICL combo increasing benefit, teasing that the second CI combo also adds benefit, so they then start a third triple combo study.

Are people not familiar with the steps one takes when seeking regulatory approvals?

Again global SAP approval happened BEFORE 10/2/20, EMA/UK posting happened after May 2021. Now what next step would trigger regulators to change Clinicaltrials.EU?

I can tell you what and it means approval is pending!